Extraneal
Active Ingredient(s): IcodextrinFDA Approved: * December 20, 2002
Pharm Company: * BAXTER HLTHCARE
Category: Diabetes
* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".
Extraneal Overview
Icodextrin (INN, USAN) is a colloid osmotic agent, derived from maltodextrin,[1] used in form of an aqueous solution for peritoneal dialysis under the trade name Extraneal,[2] and after gynecological laparoscopic surgery for the reduction of post-surgical adhesions (fibrous bands that form between tissues and organs) under the trade name Adept.[3] Contents 1 Chemistry 2 Mechanism of action 3 Pharmacokinetics 4 Contraindications 5 Adverse effec...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Icodextrin
Recent Extraneal Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Icodextrin
- Solution: 7.5gm/100ml
NDC Database Records for Extraneal: (1 result)
Sorted by National Drug Code- 0941-0679 Extraneal Intraperitoneal Injection, Solution by Baxter Healthcare Corporation